M
Miriam Schneider
Researcher at Heidelberg University
Publications - 63
Citations - 3792
Miriam Schneider is an academic researcher from Heidelberg University. The author has contributed to research in topics: Cannabinoid & WIN 55,212-2. The author has an hindex of 30, co-authored 62 publications receiving 3317 citations. Previous affiliations of Miriam Schneider include University of Cologne & University of Bremen.
Papers
More filters
Journal ArticleDOI
Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats.
Miriam Schneider,Michael Koch +1 more
TL;DR: It is concluded that puberty in rats is a vulnerable period with respect to the adverse effects of cannabinoid treatment, and chronic cannabinoid administration during pubertal development is proposed as an animal model for some aspects of the etiology of schizophrenia.
Journal ArticleDOI
Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
TL;DR: The present review provides an overview over the possible deleterious residual cannabinoid effects during critical periods of postnatal maturation and to offer a more precise delineation of the vulnerable time window for cannabinoid exposure.
Journal ArticleDOI
Oxytocin Enhances Social Recognition by Modulating Cortical Control of Early Olfactory Processing
Lars-Lennart Oettl,Namasivayam Ravi,Miriam Schneider,Max Scheller,Peggy Schneider,Mariela Mitre,Miriam da Silva Gouveia,Robert C. Froemke,Moses V. Chao,W. Scott Young,Andreas Meyer-Lindenberg,Valery Grinevich,Valery Grinevich,Roman Shusterman,Wolfgang Kelsch +14 more
TL;DR: It is observed that optogenetically induced oxytocin release enhanced olfactory exploration and same-sex recognition of adult rats and generates states for optimized information extraction in an early cortical top-down network that is required for social interactions with potential implications for sensory processing deficits in autism spectrum disorders.
Journal ArticleDOI
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use
F. Markus Leweke,Andrea Giuffrida,Dagmar Koethe,D. Schreiber,D. Schreiber,Brit M. Nolden,Laura Kranaster,Miriam A. Neatby,Miriam Schneider,C.W. Gerth,Martin Hellmich,Joachim Klosterkötter,Daniele Piomelli +12 more
TL;DR: It is indicated that frequent cannabis exposure may down-regulate anandamide signaling in the CNS of schizophrenic patients, but not of healthy individuals.
Journal ArticleDOI
Adolescence as a vulnerable period to alter rodent behavior
TL;DR: The aim of the present review is to provide a more precise delineation of the time course of these developmental periods during postnatal life in rats and mice and to discuss the impact of adolescence and related neurodevelopmental processes on the heightened susceptibility for mental disorders.